Addressing Sports-Related Muscle Injuries: PYFA Health Launches X-Cool Powered by European Cold-Therapy Technology
JAKARTA, July 20, 2026 – Public health awareness across Indonesia has surged
PYFA Wins Three Awards at IDEAS 2026, Reaffirming Its Commitment to Sustainable ESG Practices
JAKARTA, July 10, 2026 – PT Pyridam Farma Tbk (PYFA) has reinforced
PYFA Reports 11.8% Sales Growth in Q1 2026, Reinforces Focus on High-Value Products and Capacity Expansion
Pyridam Farma (PYFA) Announces Resignation of President Commissioner Robby Yulianto; New Board to be Unveiled at Upcoming AGM
Protect Your Body from Hantavirus: PYFA Medical Expert Shares Vitamin Recommendations to Boost Immunity
Enhancing Employee Fitness and Solidarity, Pyridam Farma (PYFA) Presents HYROX Through the PYFA Health Sports Community
EGMS Approves Rights Issue, PT Pyridam Farma Tbk (PYFA) Prepares for Strategic Investments and Aggressive Expansion
PYFA Sets Record Net Sales of IDR 2.76 Trillion in Fiscal Year 2025, EBITDA Reaches IDR 203.7 Billion
PYFA Production Facility in Cianjur Officially Certified ISO 45001:2018, Strengthening Its International Standard Management System
Four New Sterile Injection Production Facilities of Ethica Industri Farmasi Ready to Operate and Expand Market Reach
PYFA Supports Mandatory Halal Certification for Pharmaceutical Products, Confirms Ethica Farma Products Are Halal Certified
Pyridam Farma Wins Two Prestigious Awards at the 2026 PR Indonesia Awards (PRIA), Affirming Transparency in Pharmaceutical Industry Communications
New Hope for Premature Babies: PT Ethica Industri Farmasi Launches Caffeine Citrate Injection, Addresses Respiratory Problems in Premature Infants.
Pyridam Farma (PYFA) is Committed to Supporting Community Health to the Remote Areas of Bone Regency, South Sulawesi Through Health Service Collaboration
Supporting the Healthy Nation Program, PT Ethica Industri Farmasi – a Subsidiary of Pyridam Farma Conducts Nutritional Research to Prevent Hypertension During Pregnancy
PYFAGROUP and XtalPi: Builds a Strategic Partnership as an Initial Step in Accelerating Drug R&D with AI Based Automation and Robotic Technology
Pyridam Farma (PYFA) Records Significant Growth, Revenue Doubles with a Target of Rp 3 Trillion Next Year
